Method for analyzing side effects and interactions of pharmaceuticals

• US 20030144883A1
• Filed: 10/29/2002
• Published: 07/31/2003
• Est. Priority Date: 01/30/2002
• Status: Abandoned Application

• Current Assignee: Magnus Fagerholm, Niklas Kvarnstrom
• Original Assignee: Magnus Fagerholm, Niklas Kvarnstrom
• Inventors: Fagerholm, Magnus, Kvarnstrom, Niklas
• Application Number:
  US10/283,772
• Publication Number:
  US 20030144883A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G01N 33/94 involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 50/70 for mining of medical data, e.g. analysing previous cases of other patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

The method is a computer program for analyzing interactions between pharmaceuticals used by a patient by analyzing the prescribed pharmaceutical with a pharmaceutical profile section showing pharmaceuticals used by the patient, a diagnose profile section showing diagnose information about the patient, and an over-sensitivity profile section showing pharmaceuticals and medical substances to which the patient is sensitive. The program automatically issues warnings if the prescribed drug is incompatible with any of the pharmaceuticals or active substances of the pharmaceuticals listed in the pharmaceutical profile or over-sensitivity profile sections. The program also warns about side effects that may interfere with patient activities such as driving, breast feeding, alcohol, etc.

Claims

1. A method of analyzing interactions between pharmaceuticals used by a patient, comprising:

providing a computer program having patient data information of a patient, a pharmaceutical profile section showing pharmaceuticals used by the patient, a diagnose profile section showing diagnose information about the patient and an over-sensitivity profile section showing pharmaceuticals and medical substances to which the patient is sensitive;

analyzing a medical database linked to the computer program to determine if a prescribed pharmaceutical is incompatible with the diagnose information in the diagnose profile section and issuing a warning when the prescribed pharmaceutical is incompatible with the diagnose information;

analyzing active substances of the prescribed pharmaceutical and determining if the prescribed pharmaceutical is included in the over-sensitivity profile section and issuing a warning when the prescribed pharmaceutical is included or contains a substance that is included in the over-sensitivity profile section; and

determining if the prescribed pharmaceutical is incompatible with the pharmaceuticals of the pharmaceutical profile section and issuing a warning when the prescribed pharmaceutical is incompatible with the pharmaceuticals of the pharmaceutical profile section.

2. The method according to claim 1 wherein the method further comprises analyzing a dosage of the prescribed pharmaceutical based on the patient data information.

3. The method according to claim 1 wherein the method further comprises automatically linking the prescribed pharmaceutical to the medical database containing detailed information about the prescribed pharmaceutical.

4. The method according to claim 1 wherein the method further comprises adding the prescribed drug to the pharmaceutical profile section of the patient when the prescribed drug is not incompatible with the pharmaceuticals listed in the over-sensitivity profile section.

5. The method according to claim 1 wherein the method further comprises listing a set of patient activities and analyzing interactions between the prescribed pharmaceutical and the pharmaceuticals in the pharmaceutical profile section and issuing a warning when the interactions negatively affect at least one of the patient activities.

6. The method according to claim 1 wherein the method further comprises linking the prescribed pharmaceutical to the medical database and listing active substances of the prescribed pharmaceutical.

7. The method according to claim 1 wherein the method further comprises suggesting an alternative pharmaceutical when the prescribed pharmaceutical negatively interacts with the pharmaceuticals in the pharmaceutical profile section to produce side effects.

8. The method according to claim 1 wherein the method further comprises cumulative side effects of the pharmaceuticals of the pharmaceutical profile section.